Eslicarbazepine Acetate

SKU: orb1304346

Description

Eslicarbazepine acetate, marketed as Zebinix, is an anticonvulsant small molecule used adjunctively for refractory partial-onset seizures. Its primary research applications involve in vitro electrophysiology studies on sodium channels and in vivo models of epilepsy and neuropathic pain to investigate its mechanism and efficacy.

Research Area

Neuroscience, Pharmacology & Drug Discovery

Key Properties

• CAS Number: 236395-14-5
• MW: 296.32
• Purity: >99.99% (May vary between batches)
• Formula: C₁₇H₁₆N₂O₃
• SMILES: O(C(C)=O)[C@@H]1C=2C(N(C(N)=O)C=3C(C1)=CC=CC3)=CC=CC2
• Target: Sodium Channel,Beta-Secretase
• Solubility: H2O:< 1 mg/mL (insoluble or slightly soluble);Ethanol:9 mg/mL (30.37 mM);DMSO:40 mg/mL (134.99 mM);10% DMSO+40% PEG300+5% Tween 80+45% Saline:10 mg/mL (33.75 mM)

Storage & Handling

• Storage: Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
• Expiration Date: 12 months from date of receipt.
• Disclaimer: For research use only

Alternative Names

b-Secretase, bSecretase, BIA 2-093, BetaSecretase, Beta-secretase, BACE, Aptiom, Inhibitor, Eslicarbazepine, Eslicarbazepine Acetate, Exalief, inhibit, Na+ channels, Na channels, Zebinix, SodiumChannel, Sodium Channel, Stedesa, β-Secretase, βSecretase

Compound Identifiers

PubChem CID

179344